Patient Email from Nuplazid: “You signed up to learn more. We’re happy to help”




Brand: Nuplazid (pimavanserin), Capsules
Parent Company: Acadia Pharmaceuticals
Drug Type: Boxed Warning
Drug Category: Neurology
Campaign: Post-Launch
Targeting: Patients, Caregivers
Patient Website: https://www.nuplazid.com/
HCP Website: https://www.nuplazidhcp.com

From: ACADIA Pharmaceuticals Inc.

Sent on: Jan 21, 2019

Subject line: You signed up to learn more. We’re happy to help

Preheader: Please see Important Safety Information including Boxed WARNING at the bottom of this email.